# The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1

> **NCT05143281** · PHASE4 · COMPLETED · sponsor: **Grene Vision Group** · enrollment: 23 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Dexamethasone 0.4 MG [Dextenza]

## Key facts

- **NCT ID:** NCT05143281
- **Lead sponsor:** Grene Vision Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-13
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-02-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05143281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05143281, "The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05143281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*